SEC Form D private-offering filing

Mirum Pharmaceuticals, Inc.

Name: Mirum Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Foster City, CA
Published: 2026-01-29

A new SEC Form D private-offering notice from Foster City, CA, a $68,480,000 filer-stated offering target in Biotech. The source filing is one click away.

Mirum Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Nasdaq listed biopharmaceutical company developing treatments for rare pediatric and adult liver diseases, with approved drugs Livmarli, Cholbam, and Chenodal.

Filed 2026-01-29Filed to raise $68,480,000First money in 2026-01-23Raised so far $68,480,000HQ (as filed) Foster City, CASector Biotech ✓Stage (inferred) GrowthCall status Needs classification

Source linked the Form D on EDGAR↗Website verified mirumpharma.com↗Named in the filing 11 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.